This invention is directed to a compound of Formula I
or a pharmaceutically acceptable salt thereof, wherein X, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
and R
7
are as defined herein. The compounds of Formula I are useful as protein kinase (PK) inhibitors and can be used to treat such diseases as cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders, metabolic diseases inflammatory disorders and neurodegenerative disorders.
本发明涉及式I的化合物或其药学上可接受的盐,其中X、R1、R2、R3、R4、R5、R6和R7如本文所定义。式I的化合物可用作蛋白激酶(PK)
抑制剂,并可用于治疗癌症、血管增殖性疾病、纤维化性疾病、系膜细胞增殖性疾病、代谢性疾病、炎症性疾病和神经退行性疾病等疾病。